Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/14/2013

Company Name Symbol %Change
INTEROIL COR IOC
9.57%
INFORMATION III
9.47%
A M R CP AAMRQ
6.83%
SCIENTIFIC L SCIL
5.26%
PACER INTL I PACR
5.23%
DR Horton: 52-Week High Recently Eclipsed (DHI)

Print Share

May 13, 2013 (52 Week high-lows via COMTEX) -- Shares of DR Horton (NYSE:DHI) traded today at $27.37, breaking its 52-week high. So far today approximately 2.6 million shares have been exchanged, as compared to an average 30-day volume of 5.9 million shares.

D.R. Horton, Inc. constructs and sells single-family homes designed primarily for the entry-level and move-up markets. The Company operates in the Midwest, Mid-Atlantic, Southeast, Southwest, and Western regions of the United States. D.R. Horton also, through its financial services operations, provide mortgage financing and title agency services to homebuyers.

In the past 52 weeks, DR Horton share prices have been bracketed by a low of $14.37 and a high of $27.37 and are now at $27.26, 90% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.0% while the 50-day MA has advanced 2.0%.

DR Horton (NYSE:DHI) is currently priced 10.4% above its average consensus analyst price target of $24.42. The stock should find initial support at its 50-day moving average (MA) of $24.23 and further support at its 200-day MA of $21.37.

---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.

Copyright, Comtex News Network, Inc. 2013

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.